The pharmacokinetics, safety and tolerability of the co-administration of diethylcarbamazine and albendazole

R. K. Shenoy(T. D. Medical College), Kesara Na‐Bangchang(Thammasat University), Anil John(Pushpagiri Medical College), S Arun(T. D. Medical College), V. Kumaraswami(National Institute of Research in Tuberculosis), Lawrence Fleckenstein(University of Iowa), Takeshi Suma(T. D. Medical College)
Annals of Tropical Medicine and Parasitology
September 1, 2002
10.1179/000349802125001663
Cited by 40

Related Papers

A Worldwide Map of<i>Plasmodium falciparum</i>K13-Propeller Polymorphisms
|New England Journal of Medicine|2016|574
Artificial intelligence in medical education - perception among medical students
|BMC Medical Education|2024|121
Improvements in health-related quality of life after treatment with tocilizumab in patients with rheumatoid arthritis refractory to tumour necrosis factor inhibitors: results from the 24-week randomized controlled RADIATE study
|Lara D. Veeken|2012|106
Treatment of Human Disseminated Strongyloidiasis with a Parenteral Veterinary Formulation of Ivermectin
|Clinical Infectious Diseases|2005|102
Factors predicting successful outcome following neostigmine therapy in acute colonic pseudo‐obstruction: A prospective study
|Journal of Gastroenterology and Hepatology|2005|73